A feasibility on Acute Pancreatitis for a global clinical trial  was successfully conducted on Credevo with interesting responses from Investigators/Sites. Study details A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study to Compare the Efficacy and Safety of Ulinastatin versus Placebo in Subjects with Moderately Severe or Severe Acute Pancreatitis. Sites targeted... Read more

Credevo conducted a feasibility on AML (Acute Myeloid Leukemia) and we received a great response from Investigator/Sites. Study details The study was Phase 1 & Phase 2, Interventional, Multi-center, Randomised, Open label, Single-arm, Multiple ascending dose with patient criteria of Acute Myeloid Leukemia non eligible for intensive chemotherapy as first-line, second-line, or... Read more